Literature DB >> 29735440

[Chloroquine induces apoptosis of human hepatocellular carcinoma cells in vitro by miR-26b-mediated regulation of Mcl-1].

Xiao-Jin Sun1, Lin-Yan Ma, Meng-Xiao Zhang, Ying Wang, Pei Zhang, Chen-Chen Jiang, Hao Liu.   

Abstract

OBJECTIVE: To investigate the effect of chloroquine in inducing apoptosis of human hepatocellular carcinoma cells and explore the possible mechanism.
METHODS: MTT assay and flow cytometry were used to evaluate chloroquine-induced growth inhibition and apoptosis in human hepatocellular carcinoma HepG2 cells, respectively. The ATP levels in chloroquine-treated cells were detected using an ATP assay kit. PCR and Western blotting were used to detect the expression levels of miR-26b and Mcl-1 in the cells, respectively.
RESULTS: Chloroquine inhibited the proliferation of HepG2 cells in a time- and concentration-dependent manner. Treatments with 80 µmol/L chloroquine for 24, 48, and 72 h induced survival rates of (71.59∓0.2)%, (45.40∓0.5)%, and (26.34∓1.4)% in the cells. Treatments with chloroquine at 40, 80, and 160 µmol/L for 5 h resulted in obviously lowered intracellular ATP levels in the cells to 87.80%, 71.29%, and 38.02% of the control level, respectively. At 80 µmol/L, chloroquine significantly increased the expression of miR-26b and down-regulated the expression of Mcl-1 in HepG2 cells, and the application of the miR-26b inhibitor increased the cellular expression of Mcl-1.
CONCLUSION: s Chloroquine can inhibit the cell proliferation, reduce ATP level and induce apoptosis in HepG2 cells possibly through miR-26b-mediated regulation of Mcl-1.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29735440      PMCID: PMC6765652     

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  23 in total

1.  Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death.

Authors:  Pei-Ling Peng; Wu-Hsien Kuo; Hsien-Chun Tseng; Fen-Pi Chou
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-02-01       Impact factor: 7.038

2.  Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response.

Authors:  Yuanzheng He; Yong Xu; Chenghai Zhang; Xiang Gao; Karl J Dykema; Katie R Martin; Jiyuan Ke; Eric A Hudson; Sok Kean Khoo; James H Resau; Arthur S Alberts; Jeffrey P MacKeigan; Kyle A Furge; H Eric Xu
Journal:  Sci Signal       Date:  2011-07-05       Impact factor: 8.192

3.  Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.

Authors:  Wolfgang Sieghart; Doris Losert; Sabine Strommer; Daniel Cejka; Katharina Schmid; Susanne Rasoul-Rockenschaub; Martin Bodingbauer; Richard Crevenna; Brett P Monia; Markus Peck-Radosavljevic; Volker Wacheck
Journal:  J Hepatol       Date:  2005-10-25       Impact factor: 25.083

4.  Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.

Authors:  In Young Park; Bo Hwa Sohn; Eunsil Yu; Dong Jin Suh; Young-Hwa Chung; Je-Ho Lee; Stefan J Surzycki; Young Ik Lee
Journal:  Gastroenterology       Date:  2007-01-25       Impact factor: 22.682

5.  SB-334867-A, a selective orexin-1 receptor antagonist, enhances taste aversion learning and blocks taste preference learning in rats.

Authors:  Cristina Mediavilla; Victoria Cabello; Severiano Risco
Journal:  Pharmacol Biochem Behav       Date:  2011-02-02       Impact factor: 3.533

6.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

7.  MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.

Authors:  Raffaele Baffa; Matteo Fassan; Stefano Volinia; Brian O'Hara; Chang-Gong Liu; Juan P Palazzo; Marina Gardiman; Massimo Rugge; Leonard G Gomella; Carlo M Croce; Anne Rosenberg
Journal:  J Pathol       Date:  2009-10       Impact factor: 7.996

8.  Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell.

Authors:  San-Hua Wei; Ke Dong; Fang Lin; Xi Wang; Bin Li; Jian-Jun Shen; Qing Zhang; Rui Wang; Hui-Zhong Zhang
Journal:  Cancer Chemother Pharmacol       Date:  2008-02-23       Impact factor: 3.333

9.  Inhibition of lymphocyte mediated cytotoxicity by perforin antisense oligonucleotides.

Authors:  H Acha-Orbea; L Scarpellino; S Hertig; M Dupuis; J Tschopp
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

10.  Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer.

Authors:  Rebekah L Zinn; Eric E Gardner; Irina Dobromilskaya; Sara Murphy; Luigi Marchionni; Christine L Hann; Charles M Rudin
Journal:  Mol Cancer       Date:  2013-03-02       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.